道指跌超800点，金银大涨

Market Overview - On February 23, US stock indices faced pressure due to uncertainty surrounding tariff rulings and concerns over AI development, resulting in a collective decline. The Dow Jones fell by 1.66% to 48,804.06 points, the S&P 500 dropped by 1.04% to 6,837.75 points, and the Nasdaq decreased by 1.13% to 22,627.27 points [1] Company-Specific Developments - IBM's stock plummeted over 13%, marking its largest single-day drop since October 2000. This decline is attributed to competitive pressures from Anthropic's Claude Code, which targets IBM's reliance on legacy COBOL systems [3][7] - Other notable stock movements included Novo Nordisk, which fell over 16%, and a 32.75% drop in the 2x Long Novo Nordisk ETF, following disappointing clinical trial results for its product CagriSema compared to Eli Lilly's Zepbound. Conversely, Arcellx's stock surged over 77% due to a reported acquisition by Gilead Sciences at $115 per share [8] Tariff and Economic Policy - The US Customs and Border Protection (CBP) announced the cessation of tariffs imposed under the International Emergency Economic Powers Act (IEEPA) following a Supreme Court ruling deeming them illegal. This change is expected to influence market dynamics throughout the year [4][5] - Market analysts have differing views on the impact of tariffs. Michael Landsberg from Landsberg Bennett Private Wealth Management suggests that ongoing tariff negotiations may continue to disrupt the market, while Edward Jones' Angelo Kourkafas downplays the potential economic impact of increasing tariffs to 15% [5] Commodity Market Reaction - In response to the tariff situation, precious metals experienced gains, with COMEX gold futures rising by 0.7% to $5,262.3 and COMEX silver futures increasing by 2.18% to $88.46 [9]